• Home No adverse effects on in patients lungs AFRESA treated group observed.

No adverse effects on in patients lungs AFRESA treated group observed.

Study 030 compared to the pulmonary safety of meal – time inhalation of AFRESA compared with usual care in over 2000 patients with type-1 and type – 2 diabetes The study met its primary endpoint: After two years of treatment, no adverse effects on in patients lungs AFRESA treated group observed.

Chamber of Commerce and YMCA of the USA – fighting with the partnership with chronic illnesses.

Forward-Looking StatementsThis press release contains forward-looking statements, including statements related to the promise for AFRESA, next steps in the Company’s clinical trial program, plans and timing for the submission of an application and expectations regarding potential position and use of AFRESA in the market. Words such as believes, expects, plans, expects, intends, potential and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations of MannKind and involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, include, without limitation, risks related to progress, timing and results of clinical trials December 2007, and difficulties or delays in finding or obtaining regulatory approval for Mannkind ability in any collaborations or strategic partnerships, MannKind ‘s ability, additional financing and other risks 10 in MannKind ‘s filings with the Securities and Exchange Commission, including its Annual Report on Form collect – K for the year detailed 31st December 2007, and periodic reports on Form 10-Q and Form 8-K.The Medtronic Eureka program is designed to provide a streamlined, single point outlined for idea submissions for bringing strong partnerships between Medtronic and European inventors novel product concepts facilitate the market and improve the life of patients worldwide. Time responds to the need of physicians to a clear, simple procedures by has be evaluated the potential of its ideas by experts.

Technology. – European web portal Medical Technology Innovation stimulatesMedtronic Eureka start developed a European Portal Web in medical technology innovation to help physicians and Medical Supplies at to arouse their innovative designs to life.